3.90
Larimar Therapeutics Inc Azioni (LRMR) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
-
|
- | - | - | - |
|
10.89%
27.79
|
31.19 | 31.29 | 18.26 | 24.60 |
Operating Income/Loss |
10.89%
-27.79
|
-31.19 | -31.29 | -18.26 | -24.60 |
Nonoperating Income/Loss |
15.57%
1.61
|
1.907 | 2.469 | 2.765 | 2.972 |
Income/Loss From Continuing Operations Before Tax |
10.58%
-26.18
|
-29.28 | -28.82 | -15.50 | -21.63 |
Income Tax Expense/Benefit |
-
|
- | - | - | - |
Income/Loss From Continuing Operations After Tax |
10.58%
-26.18
|
-29.28 | -28.82 | -15.50 | -21.63 |
|
10.58%
-26.18
|
-29.28 | -28.82 | -15.50 | -21.63 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
0.10%
64.03
|
63.96 | 0.8564 | 63.81 | 63.80 |
Diluted Average Shares |
0.10%
64.03
|
63.96 | 0.8564 | 63.81 | 63.80 |
Basic Earnings Per Share |
10.87%
-0.41
|
-0.46 | -0.46 | -0.24 | -0.34 |
Diluted Earnings Per Share |
10.87%
-0.41
|
-0.46 | -0.46 | -0.24 | -0.34 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):